True for healtcare too: more transparency means lower prices. creates price transparency for medical implants and high-value pharmaceuticals, thereby enabling hospitals to reduce procurement costs. As a side effect, there is more time for important things like lifecycle costs and sustainability.
Our goal is to give our members full visibility of invoices and other terms & conditions from as many hospitals as possible. Reciprocally, our members allow access to their procurement terms. lets you do this completely anonymously. Read more...
is not-for-profit and its membership fee surprisingly low.
Don't miss out: become a member today!
is not-for-profit:
become a member today!
According to manufacturers, prices (P) are reasonably correlated with the number of implants that a hospital buys (Q)—the green dots on the chart. Moreover, everybody gets treated similarly and margins for manufacturers are low.
Fact is that prices are completely random—the red dots on the chart—and size is irrelevant to get the best prices.
Prices for implants and pharmaceuticals follow a bell-shaped curve: some pay low prices (green on the chart), some pay premium (red) and many sit somewhere in the middle (blue). But most buyers will claim their prices are in the lower quartile.
In reality, 75% of hospitals pay prices for medical implants that are NOT in the lower 25%.
Buying groups only see part of the market: just the blue-circled dots in the chart. They add their overhead costs (C) to a negotiated price, and that's what their members pay.
Truth is that direct buyers regularly undercut buying groups significantly (see the green-circled dot on the chart).
From the desktop in your office, from your tablet and also from your mobile phone: You can access medixfair's price information wherever you are.